Advances in cancer treatments have improved clinical outcomes, leading to an increasing
population of cancer survivors. However, this success is associated with high rates of short …

Aims Anticancer therapies have extended the lives of millions of patients with malignancies,
but for some this benefit is tempered by adverse cardiovascular (CV) effects. Cardiotoxicity …

Cardiotoxicity due to cancer treatment is of rising concern, for both cardiologists and
oncologists, because it may have a significant impact on cancer patient management and …

Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

Modern treatment strategies have led to improvements in cancer survival, however, these
gains might be offset by the potential negative effect of cancer therapy on cardiovascular …

Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …

Advances in cancer screening and improved treatment approaches have led to an increase
in survivorship and, consequently, recognition of an association between cancer treatments …

Background The diagnosis and management of cardiovascular complications have become
a clinical concern for oncologists, cardiologists, surgeons, interventional radiologists …

Current therapy of advanced cancers is based on several modalities including radiotherapy,
cytotoxic chemotherapy, molecularly targeted inhibitors and antibodies targeting immune …

The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …